We are live on
!
Find out more
ANI Pharmaceuticals
ANIP
ANIP
72 hedge funds and large institutions have $128M invested in ANI Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 32 increasing their positions, 20 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
60% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 20
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less funds holding
Funds holding: 81 → 72 (-9)
18% less capital invested
Capital invested by funds: $156M → $128M (-$27.8M)
60% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 15
Holders
72
Holders Change
-9
Holders Change %
-11.11%
% of All Funds
2.09%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
32
Reduced
20
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
Millennium Management
New York
|
-$7.79M |
| 2 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$5.17M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
-$3.03M |
| 4 |
Morgan Stanley
New York
|
-$3.01M |
| 5 |
Renaissance Technologies
New York
|
-$2.68M |
